![Xi Liu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Perfil
Xi Liu served as an Independent Director at I-Mab in 2021-2022.
Prior to that, Liu earned an undergraduate degree from China Agricultural University in 2006 and a doctorate from the University of Pittsburgh School of Medicine in 2011.
Antiguos cargos conocidos de Xi Liu.
| Empresas | Cargo | Fin |
|---|---|---|
| NOVABRIDGE BIOSCIENCES | Director/Miembro de la Junta | 31/08/2022 |
Formación de Xi Liu.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
17
Relaciones de 1er grado
3
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
China Agricultural University
 China Agricultural University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pittsburgh School of Medicine
 University of Pittsburgh School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
I-Mab
 I-Mab Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for cancer and autoimmune diseases | Health Technology |
- Bolsa de valores
- Insiders
- Xi Liu
Elige MarketScreener 
